PT-141 (Bremelanotide) is a melanocortin receptor agonist developed from Melanotan II specifically for sexual dysfunction research. Unlike PDE5 inhibitors (such as sildenafil), PT-141 works directly in the central nervous system to activate sexual arousal pathways via MC3R and MC4R receptor activation. It is studied for its centrally-acting mechanism in preclinical sexual function and neuroendocrine research.
PT-141
SKU: 26
$50.00Price
- Centrally-acting sexual arousal research tool — activates melanocortin pathways in the CNS
- Studied for sexual dysfunction research via distinct CNS mechanism from PDE5 inhibitors
- Does not require sexual stimulation to be initiated (unlike PDE5 inhibitors)
- Reduced tanning/pigmentation activity compared to Melanotan II
